Clinical Trial Update: Treatment Of Patients With Social Anxiety Disorder [Phase 2]

View source ↗

Summary

GlaxoSmithKline's Phase 2 trial for Social Anxiety Disorder has completed, according to the clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Investigational Compound

Snippet

Sponsor: GlaxoSmithKline | Conditions: Social Phobia | Phase 2 | Status: COMPLETED